Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideki Fujii

Showing results (91-100 of 556) with videos related to

Pageof 56
Sort By:
Journal of Nephrology|January 11, 2020
Changes in the whole/intact parathyroid hormone ratio and their clinical implications in patients with chronic kidney diseaseKohei Okamoto, Hideki Fujii, Shunsuke Goto, et al.
The Kobe Journal of Medical Sciences|October 4, 2005
Life-threatening hyperkalemia during a combined therapy with the angiotensin receptor blocker candesartan and spironolactoneHideki Fujii, Hajime Nakahama, Fumiki Yoshihara, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 8, 2016
Comparison of the effects of novel vitamin D receptor analog VS-105 and paricalcitol on chronic kidney disease-mineral bone disorder in an experimental model of chronic kidney diseaseHideki Fujii, Yuriko Yonekura, Kentaro Nakai, et al.
Clinical Kidney Journal|September 29, 2016
Serum FGF23 levels may not be associated with serum phosphate and 1,25-dihydroxyvitamin D levels in patients with Fanconi syndrome-induced hypophosphatemiaShunsuke Goto, Hideki Fujii, Keiji Kono, et al.
Internal Medicine (Tokyo, Japan)|February 19, 2025
Dapagliflozin for the treatment of collagenofibrotic glomerulopathyEnyu Imai, Atsuhiro Imai, Masaaki Izumi, et al.
Frontiers in Endocrinology|January 4, 2024
Exploring the implications of blocking renin-angiotensin-aldosterone system and fibroblast growth factor 23 in early left ventricular hypertrophy without chronic kidney diseaseKentaro Watanabe, Hideki Fujii, Kohei Okamoto, et al.
Case Reports in Nephrology and Dialysis|April 12, 2016
Two Cases of Hypophosphatemia with Increased Renal Phosphate Excretion in Legionella PneumoniaShuhei Watanabe, Keiji Kono, Hideki Fujii, et al.
Oncology|February 1, 2006
A newly identified MAGE-3-derived, HLA-A24-restricted peptide is naturally processed and presented as a CTL epitope on MAGE-3-expressing gastrointestinal cancer cellsNaoto Miyagawa, Koji Kono, Kousaku Mimura, et al.
American Journal of Nephrology|February 22, 2011
Effects of AST-120 on left ventricular mass in predialysis patientsKentaro Nakai, Hideki Fujii, Keiji Kono, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 24, 2004
[Generation of HER2 specific, HLA-A24 restricted CTLs derived from a healthy donor]Kousaku Mimura, Koji Kono, Naoto Miyagawa, et al.
Pageof 56

Showing results (91-100 of 556) with videos related to

Sort By:
Pageof 56
Journal of Nephrology|January 11, 2020
Changes in the whole/intact parathyroid hormone ratio and their clinical implications in patients with chronic kidney diseaseKohei Okamoto, Hideki Fujii, Shunsuke Goto, et al.
The Kobe Journal of Medical Sciences|October 4, 2005
Life-threatening hyperkalemia during a combined therapy with the angiotensin receptor blocker candesartan and spironolactoneHideki Fujii, Hajime Nakahama, Fumiki Yoshihara, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 8, 2016
Comparison of the effects of novel vitamin D receptor analog VS-105 and paricalcitol on chronic kidney disease-mineral bone disorder in an experimental model of chronic kidney diseaseHideki Fujii, Yuriko Yonekura, Kentaro Nakai, et al.
Clinical Kidney Journal|September 29, 2016
Serum FGF23 levels may not be associated with serum phosphate and 1,25-dihydroxyvitamin D levels in patients with Fanconi syndrome-induced hypophosphatemiaShunsuke Goto, Hideki Fujii, Keiji Kono, et al.
Internal Medicine (Tokyo, Japan)|February 19, 2025
Dapagliflozin for the treatment of collagenofibrotic glomerulopathyEnyu Imai, Atsuhiro Imai, Masaaki Izumi, et al.
Frontiers in Endocrinology|January 4, 2024
Exploring the implications of blocking renin-angiotensin-aldosterone system and fibroblast growth factor 23 in early left ventricular hypertrophy without chronic kidney diseaseKentaro Watanabe, Hideki Fujii, Kohei Okamoto, et al.
Case Reports in Nephrology and Dialysis|April 12, 2016
Two Cases of Hypophosphatemia with Increased Renal Phosphate Excretion in Legionella PneumoniaShuhei Watanabe, Keiji Kono, Hideki Fujii, et al.
Oncology|February 1, 2006
A newly identified MAGE-3-derived, HLA-A24-restricted peptide is naturally processed and presented as a CTL epitope on MAGE-3-expressing gastrointestinal cancer cellsNaoto Miyagawa, Koji Kono, Kousaku Mimura, et al.
American Journal of Nephrology|February 22, 2011
Effects of AST-120 on left ventricular mass in predialysis patientsKentaro Nakai, Hideki Fujii, Keiji Kono, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 24, 2004
[Generation of HER2 specific, HLA-A24 restricted CTLs derived from a healthy donor]Kousaku Mimura, Koji Kono, Naoto Miyagawa, et al.
Pageof 56